TY  - BOOK
ED  - United States.
TI  - Antitrust concerns and the FDA approval process: hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017
AV  - KF27 .J874 2017h
PY  - 2018///
CY  - Washington
PB  - U.S. Government Publishing Office
KW  - United States
KW  - Food and Drug Administration
KW  - Rules and practice
KW  - Drugs
KW  - Testing
KW  - Drug approval
KW  - Safety regulations
KW  - Medical instruments and apparatus
KW  - Generic drugs
KW  - Competition
KW  - Antitrust law
KW  - Legislative hearings
KW  - lcgft
N1  - "Serial no. 115-27."; CRDP Program record
UR  - https://purl.fdlp.gov/GPO/gpo93483
ER  -